Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4129805
Max Phase: Preclinical
Molecular Formula: C22H27N3O2
Molecular Weight: 365.48
Molecule Type: Small molecule
Associated Items:
ID: ALA4129805
Max Phase: Preclinical
Molecular Formula: C22H27N3O2
Molecular Weight: 365.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N#Cc1ccc(O[C@@H]2[C@@H]3[C@H](C[C@H]2N2CCC[C@@H](N)C2)[C@@H]2CC(=O)[C@H]3C2)cc1
Standard InChI: InChI=1S/C22H27N3O2/c23-11-13-3-5-16(6-4-13)27-22-19(25-7-1-2-15(24)12-25)10-17-14-8-18(21(17)22)20(26)9-14/h3-6,14-15,17-19,21-22H,1-2,7-10,12,24H2/t14-,15+,17+,18+,19+,21+,22-/m0/s1
Standard InChI Key: IRQSLZMCJNUIOZ-ILJMKYQKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 365.48 | Molecular Weight (Monoisotopic): 365.2103 | AlogP: 2.34 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.35 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.46 | CX LogP: 2.15 | CX LogD: 0.10 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.89 | Np Likeness Score: 0.67 |
1. Motoyama K, Nagata T, Kobayashi J, Nakamura A, Miyoshi N, Kazui M, Sakurai K, Sakakura T.. (2018) Discovery of a bicyclo[4.3.0]nonane derivative DS88790512 as a potent, selective, and orally bioavailable blocker of transient receptor potential canonical 6 (TRPC6)., 28 (12): [PMID:29752182] [10.1016/j.bmcl.2018.03.056] |
Source(1):